Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis

Phase 1 Completed 30 enrolled Regional Hospital Holstebro

RandomizedCrossoverSingle-blind

Summary

Phase 1 study of the effects of nitric oxide inhibition with L-NMMA in patients with liver cirrhosis and healthy controls. It is hypothesized that nitric oxide availability is increased in liver cirrhosis.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	L-NMMA	Unknown	—	—

Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis

Summary

Timeline

Drugs

Indications